Jump Financial’s CorMedix CRMD Stock Holding History

Jump Financial’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	+180,027	New	+$1.42M	0.01%	1030
2026 Q1	–	Sell	-136,790	Closed	-$1.59M	–	1973
2025 Q4	$1.59M	Sell	136,790 -637,293	-82%	-$7.05M	0.02%	775
2025 Q3	$9M	Buy	+774,083	New	+$9.36M	0.11%	244
2024 Q2	–	Sell	-12,300	Closed	-$52.2K	–	1876
2024 Q1	$52.2K	Sell	12,300 -58,385	-83%	-$202K	﹤0.01%	1830
2023 Q4	$266K	Buy	+70,685	New	+$243K	0.01%	1399
2023 Q2	–	Sell	-36,020	Closed	-$149K	–	1859
2023 Q1	$149K	Sell	36,020 -8,307	-19%	-$34K	0.01%	1371
2022 Q4	$187K	Buy	44,327 +13,589	+44%	+$48.1K	0.01%	1306
2022 Q3	$87K	Sell	30,738 -6,562	-18%	-$27.3K	﹤0.01%	1458
2022 Q2	$150K	Buy	+37,300	New	+$139K	0.01%	1367
2022 Q1	–	Sell	-27,400	Closed	-$124K	–	1603
2021 Q4	$124K	Buy	+27,400	New	+$136K	0.01%	1195

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jump Financial's CRMD Position: Q2 2026 in Review

Jump Financial opened a new position in CorMedix (CRMD) in Q2 2026: 180,027 shares worth $1.41M. The stake represents 0.01% of the portfolio and ranks #1030 among its holdings. This is a return to the name: Jump Financial previously reported a position in CRMD as recently as Q4 2025.

Jump Financial first reported a position in CRMD in Q4 2021 and has held it in 10 quarters since. The position peaked at $9M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Jump Financial held 180,027 shares of CorMedix worth $1.41M as of Q2 2026.
CorMedix was a new Jump Financial position in Q2 2026.
CorMedix made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1030 holding.
Jump Financial first reported a position in CorMedix in Q4 2021 and has held it in 10 quarters since.
Jump Financial's CorMedix position peaked at $9M in Q3 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.